Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET SAFE: 1 vs 6 Months DAPT in HBR Patients with Firehawk Stent
NCT03287167Phase 4Unknown
- Sponsor
- MicroPort
- Start
- Jun 2019
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel in coronary artery disease (CAD), sponsored by MicroPort. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03287167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287167.